business

J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

Investing.com · May 31, 2026, 12:06 PM · Also reported by 3 other sources

Read full story on Investing.com → More top stories

Also covered by

ARY News Erleada: Prostate cancer drug reduces risk of spread and death CNBC A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China STAT News STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

Also covered by

More in business